Seeking Alpha

Sucampo Pharmaceuticals (SCMP -0.8%) and Abbott (ABT -0.6%) launch Amitiza, a prescription...

Sucampo Pharmaceuticals (SCMP -0.8%) and Abbott (ABT -0.6%) launch Amitiza, a prescription medicine for the treatment of chronic constipation, in Japan. The drug was approved by the Japanese Ministry of Health, Labor and Welfare in Japan in June. ABT will promote and distribute Amitiza in Japan under the terms of a 2009 license agreement with SCMP.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|